FRANK MORGAN C. 4

What Happened
Frank Morgan, Chief Executive Officer of SANUWAVE Health, Inc. (SNVW), was granted a derivative award on January 30, 2026 that covers 24,000 shares. The filing reports an acquisition at $0.00 (no immediate cash outlay reported) and classifies the instrument as a derivative. A footnote clarifies these are options that will vest in four equal installments on the last day of each quarter in 2026 (6,000 shares vesting per quarter).

Key Details

• Transaction date: 2026-01-30; Form 4 filed: 2026-02-03 (filed within the required two business days).
• Transaction type/code: Award/Grant (A) — derivative (options) acquired at reported price $0.00.
• Number of shares/options granted: 24,000 total; vesting schedule: four equal installments (6,000 each) on the last day of each quarter in 2026 (per footnote F1).
• Amount realized / cash paid: $0.00 reported at grant (no immediate purchase price).
• Shares owned after transaction: Not specified in the filing.
• No 10b5-1 plan, tax-withholding, or late-filing flags noted in the filing.

Context
This is a compensation grant (options) to the CEO rather than an open-market purchase or sale. Such awards are common for management incentive pay and do not by themselves indicate the insider is buying or selling stock on the market. The economic benefit will depend on vesting and any future exercise terms and the company’s share price at those times.